Role of PCSK9 in the Development of Mouse Periodontitis Before and After Treatment: A Double-Edged Sword-Reference-Cited by-同舟云学术

Role of PCSK9 in the Development of Mouse Periodontitis Before and After Treatment: A Double-Edged Sword

Published:2017-12-23 Issue:4 Volume:217 Page:667-680
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Sun Hua Ling¹,Wu Yan Ru¹,Song Fang Fang¹,Gan Jing¹,Huang Li Yuan¹,Zhang Lu¹,Huang Cui¹

Affiliation:

1. State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Hubei, People’s Republic of China

Funder

National Natural Science Foundation of China

Fundamental Research Fund for the Central Universities

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/217/4/667/23694227/jix574.pdf

Reference47 articles.

1. The global burden of periodontal disease: towards integration with chronic disease prevention and control;Petersen;Periodontol 2000,2012

2. Inflammatory reaction—communication of cells;Terheyden;Clin Oral Implants Res,2014

3. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression;Kassebaum;J Dent Res,2014

4. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis;Maekawa;Cell Host Microbe,2014

5. Periodontology: past, present, perspectives;Slots;Periodontol 2000,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

2. Atherosclerosis and Toll-Like Receptor4 (TLR4), Lectin-Like Oxidized Low-Density Lipoprotein-1 (LOX-1), and Proprotein Convertase Subtilisin/Kexin Type9 (PCSK9);Mediators of Inflammation;2024-02-27

3. Genetically proxied PCSK9 inhibition is associated with reduced psoriatic arthritis risk;Inflammation Research;2024-02-11

4. A bibliometric analysis of PCSK9 inhibitors from 2007 to 2022;Frontiers in Endocrinology;2023-11-29

5. Green Alternatives as Antimicrobial Agents in Mitigating Periodontal Diseases: A Narrative Review;Microorganisms;2023-05-11